Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06333587

Minimally Invasive Treatments of the Thyroid

Multicenter International Prospective Analysis on Minimally Invasive Treatments of the Thyroid (MIPA- MITT) of of Micropapillary Thyroid Carcinoma

Status
Recruiting
Phase
Study type
Observational
Enrollment
270 (estimated)
Sponsor
European Institute of Oncology · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a prospective cohort study to test Minimally Invasive Treatments of the Thyroid (MITT) as potential alternative to surgery in patients with Papillary Thyroid MicroCarcinoma (PTMC)

Detailed description

Image-guided thermal ablations have been successfully applied in the treatment of several type of tumors, and have been recently proposed as a potential alternative to surgery also in patients with thyroid diseases, and named "Minimally Invasive Treatments of the Thyroid (MITT)". These minimally invasive treatments, compared to surgical treatment have similar efficacy, fewer complications, better quality of life, and better cosmetic outcomes. These procedures allow precise delivery of the heat locally to the lesion, sparing the surrounding thyroid tissue, and thus minimizing the invasiveness of the treatment and the impact on thyroid function. This study aim to establish a prospective registry of the cases of patients treated with MITT for a Papillary Thyroid MicroCarcinoma (PTMC), in order to validate the safety of the procedure and to set the basis for collecting long term results in a large cohort of patients.

Conditions

Interventions

TypeNameDescription
PROCEDUREimage-guided thermal ablationimage-guided thermal ablation in patients with diagnosis of micropapillary thyroid carcinoma

Timeline

Start date
2022-10-10
Primary completion
2025-12-31
Completion
2035-12-31
First posted
2024-03-27
Last updated
2024-03-27

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06333587. Inclusion in this directory is not an endorsement.